Antineoplastic effects of 15(S)‐hydroxyeicosatetraenoic acid and 13‐S‐hydroxyoctadecadienoic acid in non–small cell lung cancer

Publisher： John Wiley & Sons Inc

E-ISSN： 1097-0142|121|S17|3130-3145

ISSN： 0008-543x

Source： CANCER, Vol.121, Iss.S17, 2015-09, pp. : 3130-3145

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Lack of association of ALOX12 and ALOX15B polymorphisms with psoriasis despite altered urinary excretion of 12(S)‐hydroxyeicosatetraenoic acid

By  

BRITISH JOURNAL OF DERMATOLOGY, Vol. 172, Iss. 2, 2015-02 ,pp. : 337-344

John Wiley & Sons Inc

Access to resources Recommend Favorite

Pharmacokinetic Study of Weekly (Days 1-5) Low-dose S-1 in Patients with Non-Small-Cell Lung Cancer

By  

Reviews on Recent Clinical Trials, Vol. 7, Iss. 2, 2012-05 ,pp. : 167-172

Bentham Science Publishers

Access to resources Recommend Favorite

Expression of p53 and Glutathione S-Transferase-π Relates to Clinical Drug Resistance in Non-Small Cell Lung Cancer

By  

Oncology, Vol. 57, Iss. 4, 1999-11 ,pp. : 318-323

Karger

Access to resources Recommend Favorite

Long-Term Survival after Second-Line Therapy with Docetaxel and Carboplatin and Monthly Pamidronic Acid in a Woman with Metastatic Non-Small Cell Lung Cancer

By  

Oncology Research and Treatment, Vol. 29, Iss. 5, 2006-05 ,pp. : 206-208

Karger

Access to resources Recommend Favorite

Toxic Epidermal Necrolysis Related to Pemetrexed and Carboplatin with Vitamin B12 and Folic Acid Supplementation for Advanced Non-Small Cell Lung Cancer

By  

Oncology Research and Treatment, Vol. 32, Iss. 10, 2009-09 ,pp. : 580-584

Karger

Access to resources Recommend Favorite